Dr. Holzbeierlein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
Stop 3016
Kansas City, KS 66160Phone+1 913-588-6147Fax+1 913-588-7625
Education & Training
Vanderbilt University Medical CenterResidency, Urology, 1996 - 2000
University of Tennessee College of Medicine (Nashville)Residency, Surgery, 1994 - 1996
University of Oklahoma College of MedicineClass of 1994
Certifications & Licensure
KS State Medical License 2002 - 2025
MO State Medical License 2010 - 2025
NY State Medical License 2000 - 2002- American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy Start of enrollment: 2004 Aug 01
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
- Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 567 citationsARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate CancerAndrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Arnauld Villers
Journal of Clinical Oncology. 2019-07-22 - 141 citationsSurvival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma ...Asim Amin, Arkadiusz Z. Dudek, Theodore F. Logan, Raymond S. Lance, Jeffrey M. Holzbeierlein
Journal for Immunotherapy of Cancer. 2015-04-21 - 33 citationsThe Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition.Sanket J. Mishra, Weiya Liu, Kristin Beebe, Monimoy Banerjee, Caitlin N. Kent
Journal of Medicinal Chemistry. 2021-01-11
Press Mentions
Spotlight: Dr. Susan Lee, MDMay 22nd, 2024- AUA/SUO Release an Amendment to the Advanced Prostate Cancer GuidelineMay 2nd, 2023
- AUA/SUO Release an Amendment to the Advanced Prostate Cancer GuidelineApril 25th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
